TrialBritish journal of cancer2018

Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.

Brigette Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.